Itamar Medical (TASE:ITMR) announced that it upsized and priced a public offering of American depository shares (ADSs) for total gross proceeds of approximately $35 million. The Caesarea, Israel–based respiratory sleep disorder treatment developer offered more than 2.5 million ADSs at a public offering price of $13.75 per ADS to reach the $35 million mark before the […]
Ascyrus Medical raises $5.2m
Aortic dissection stent graft maker Ascyrus Medical announced that it sold nearly $5.2 million in an equity offering. The Boca Raton, Fla.–based company has no equity left to be sold in the offering, having collected approximately $5.18 million from six different investors. The minimum investment accepted was $39,997. Ascyrus Medical did not disclose the issuer […]
Rani Therapeutics could go the IPO route
Rani Therapeutics is reportedly moving forward with an early-stage efficacy and safety study for its robotic pills and may be on its way toward the possibility of an IPO. According to a report in Endpoints News, Rani, led by CEO Mir Imran who shared the story on LinkedIn, revealed that its RaniPill performed as expected with 58 […]
PhysIQ awarded $500,000 for AI research
PhysIQ, a Purdue University-affiliated artificial intelligence company, announced today that it received a $500,000 investment from the Purdue Research Foundation’s Foundry Investment Fund to help the company advance its medical technology. West Lafayette, Ind.–based PhysIQ develops healthcare solutions by applying AI to real-time physiological data from wearable sensors. The company’s FDA-cleared technology is designed to […]
Vascular Therapies closes $17.3m financing
Vascular Therapies announced that it closed an upsized private funding round worth more than $17 million with contributions from new and existing investors. The Cresskill, N.J.–based clinical-stage biopharma company originally targeted $15 million for the financing, but finished with a total of $17.3 million raised. Vascular Therapies intends to put the proceeds toward the advancement […]
Aethlon Medical completes $3.8m offering
Aethlon Medical (NSDQ:AEMD) announced that it completed its previously announced registered direct offering of nearly 1.9 million shares of its common stock for nearly $3.8 million in proceeds. The shares, offered at a purchase price of $2 per share, totaled approximately $3.77 million in gross proceeds. Aethlon additionally issued unregistered warrants to purchase up to 942,689 […]
St. Jude Medical founder and his Medical 21 raise $1.1m
St. Jude Medical founder Manny Villafaña’s Medical 21 filed an amendment to an SEC Form D to reveal that it raised more than $1.1 million in an equity offering. The Minneapolis-based company raised a total of $1.14 million in a $10 million offering, leaving $8.86 million remaining to be sold, according to the SEC filing. […]
Nanox Imaging raises $26m
Nanox Imaging announced today that it secured $26 million in funding in support of the development, commercialization and deployment of its Nanox System for early detection of medical conditions. With participation from strategic investor Foxconn, along with Fujifilm (TSE:4901), SK Telecom and other private investors, Neve Ilan, Israel-based Nanox said its total funding is now at […]
Proteus pivots, hands digital mental health adherence business to Otsuka
Proteus Digital Health is abandoning its mental illness and cardiovascular work in its digital pill technology after its deal with Otsuka Pharmaceutical (TYO:4578) ended prematurely and will start to focus more on therapeutic areas, STAT News reports. Otsuka Pharmaceutical had been paying Proteus to develop a portfolio of digital medicines for serious mental health conditions. […]
Embody lands $2.5m from DARPA
Soft-tissue repair treatment developer Embody announced that it has landed a $2.5 million grant from the Defense Advanced Research Projects Agency (DARPA). The latest DARPA funding brings Norfolk, Va.-based Embody’s total DARPA non-dilutive funding to nearly $14.4 million, according to a news release. Embody plans to use the Phase II Small Business Innovation Research (SBIR) […]
Reva Medical files for bankruptcy
Reva Medical (ASX:RVA) announced today that it has filed for Chapter 11 bankruptcy protection. San Diego-based Reva — which specializes in bioresorbable polymer tech for vascular applications — entered into a restructuring support agreement with a handful of its stakeholders last month. The goal was to address the company’s outstanding debt. Reva also filed a prepackaged […]
MassDevice Network
@MassDevice
LinkedIn
YouTube